School of Systems Biomedical Science, Soongsil University, Seoul, Korea.
Hum Mutat. 2012 Apr;33(4):655-9. doi: 10.1002/humu.22040. Epub 2012 Feb 20.
Genome-wide associations with glycosylated hemoglobin, which reflects the long-term glycemia, were examined using two independent cohorts of the Korea Association Resource (KARE) consortium. We first identified sequence variants within a linkage disequilibrium block (r(2) > 0.98) in the intron 5 of cyclin-dependent kinase 5 regulatory subunit-associated protein 1-like 1 (CDKAL1) gene using 4,275 normoglycemic subjects of Cohort 1 (P < 2.5 × 10(-8)). The association was replicated in 3,782 normoglycemic subjects of Cohort 2. Furthermore, the sequence variants were also associated with glucose levels after oral glucose tolerance test. Especially, a strong association with 1 h glucose (P = 1.3 × 10(-11)) led us to interpreting that CDKAL1 might influence the level of glycosylated hemoglobin by affecting 1 h glucose level. Ultimately, accumulated effects on the glycosylated hemoglobin level by the genetic variation of CDKAL1 might affect susceptibility to type 2 diabetes mellitus.
采用韩国关联资源(KARE)联合会的两个独立队列,对反映长期血糖水平的糖化血红蛋白的全基因组关联进行了研究。我们首先使用队列 1 的 4275 名血糖正常的受试者(P < 2.5 × 10(-8)),在细胞周期蛋白依赖性激酶 5 调节亚单位相关蛋白 1 样 1(CDKAL1)基因的内含子 5 中确定了连锁不平衡块(r(2) > 0.98)内的序列变异。在队列 2 的 3782 名血糖正常的受试者中对该关联进行了复制。此外,这些序列变异还与口服葡萄糖耐量试验后的葡萄糖水平相关。特别是,与 1 小时葡萄糖的强烈关联(P = 1.3 × 10(-11))使我们认为,CDKAL1 可能通过影响 1 小时葡萄糖水平来影响糖化血红蛋白水平。最终,CDKAL1 的遗传变异对糖化血红蛋白水平的累积影响可能会影响 2 型糖尿病的易感性。